Overview Phase III Study of TS-142 in Patients With Insomnia Status: Not yet recruiting Trial end date: 2024-01-01 Target enrollment: Participant gender: Summary This is a randomized, double-blind, multi-center, placebo-controlled, parallel-group confirmatory study in patients with insomnia. Phase: Phase 3 Details Lead Sponsor: Taisho Pharmaceutical Co., Ltd.